Авраам Злотогорский

Научные публикации

• Management of Atopy with Dupilumab and Omalizumab in CADINS Disease
• Familial oral lichen planus: A new risk group for oral cancer?
• Bullous Hemorrhagic Target Lesions in IgA Leukocytoclastic Vasculitis
• Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
• Retraction Notice to "Generalized verrucosis and abnormal T cell activation due to homozygous TAOK2 mutation"
• Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic marker in metastatic melanoma
• Efficacy of ultraviolet A1 phototherapy for inflammatory, sclerotic and neoplastic dermatological diseases: A 10-year tertiary referral center experience
• Sechs Fälle von Pityriasis rosea nach SARS-CoV-2-Impfung mit BNT162b2
• The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma
• Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2
• Two Phase 3 Trials of Baricitinib for Alopecia Areata
• Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
• Acral peeling skin syndrome resulting from a novel homozygous mutation in the CSTA gene-A report of two cases
• Subcutaneous Levodopa Infusion for Parkinson's Disease: 1-Year Data from the Open-Label BeyoND Study
• Exacerbation of Hailey-Hailey Disease Following SARS-CoV-2 Vaccination
• Can Tofacitinib Offer Protection against COVID-19 Infection?
• Chronic demodicosis in patients with immune dysregulation: An unexpected infectious manifestation of Signal transducer and activator of transcription (STAT)1 gain-of-function
• Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)
• Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2
• Wax Stripping and Isotretinoin Treatment: A Warning Not to Be Missed
• The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases
• An Update on the Cutaneous Manifestations of Darier Disease
• A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
• Multiple Nasal Papules in a 12-year-old Boy: A Quiz
• The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata
• The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
• Hirsutism Induced by Facial Autologous Fat Grafting
• JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA
• EFFECTIVE TREATMENT FOR BULLOUS PEMPHIGOID WITH OMALIZUMAB
• STAT1 gain-of-function and chronic demodicosis
• Epidemiology and Comorbidities of Psoriasis among Israeli Adolescents: A Large Cross-Sectional Study
• Phototherapy decreases red blood cell deformability in patients with psoriasis
• Spontaneous Quick Resolution of Uncombable Hair Syndrome-Like Disease
• Dermatology today and tomorrow: from symptom control to targeted therapy
• Solitary angiokeratoma of the vulva mimicking malignant melanoma
• Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
• Proceedings of the Ninth World Congress for Hair Research (2015)
• RETRACTED: Generalized verrucosis and abnormal T cell activation due to homozygous TAOK2 mutation
• Atopic Dermatitis in Israeli Adolescents from 1998 to 2013: Trends in Time and Association with Migraine
• Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent
• Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate
• Janus kinase inhibitors in dermatology: A systematic review
• Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function-associated Multi-organ Autoimmune Syndrome
• Alopecia Areata as a Manifestation of Systemic Lymphoma: Report of Two Cases
• Successful treatment of refractory Darier disease with alitretinoin with a follow up of over a year: a case report
• Response to 'Darier disease in Israel: combined evaluation of genetic and neuropsychiatric aspects': reply from the authors
• Multilesional cutaneous leishmaniasis
• Two Episodes of Simultaneous Identical Alopecia Areata in Identical Twins
• Squamous cell carcinoma in situ in association with HPV 11 in Netherton's syndrome patient: a case report
• Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production